Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 5, 2006, Pages

  Xiang, Fan ^a   Sakata, Yasuhiko ^a,c   Cui, Lei ^b   Youngblood, Joey M ^a   Nakagami, Hironori ^a   Liao, James K ^b   Liao, Ronglih ^a   Chin, Michael T ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Transgenic mouse

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; PHENYLEPHRINE; PROTEIN CHF 1; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CARDIOMEGALY; CELLS, CULTURED; GATA4 TRANSCRIPTION FACTOR; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; PHENYLEPHRINE; PROTEIN BINDING; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 33646415903     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01106.2005     Document Type: Article

References (46)

1. Akazawa H and Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92: 1079-1088, 2003.
2. Chen F, Kook H, Milewski R, Gitler AD, Lu MM, Li J, Nazarian R, Schnepp R, Jen K, Biben C, Runke G, Mackay JP, Novotny J, Schwartz RJ, Harvey RP, Mullins MC, and Epstein JA. Hop is an unusual homeobox gene that modulates cardiac development. Cell 110: 713-723, 2002.
3. Chin MT, Maemura K, Fukumoto S, Jain MK, Layne MD, Watanabe M, Hsieh CM, and Lee ME. Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system. J Biol Chem 275: 6381-6387, 2000.
4. Deng XF, Rokosh DG, and Simpson PC. Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat. Circ Res 87: 781-788, 2000.
5. Donovan J, Kordylewska A, Jan YN, and Utset MF. Tetralogy of Fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol 12: 1605-1610, 2002.
6. Durocher D, Charron F, Warren R, Schwartz RJ, and Nemer M. The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J 16: 5687-5696, 1997.
7. Elagib KE, Xiao M, Hussaini IM, Delehanty LL, Palmer LA, Racke FK, Birrer MJ, Shanmugasundaram G, McDevitt MA, and Goldfarb AN. Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2. Mol Cell Biol 24: 7779-7794, 2004.
8. Fischer A and Gessler M. Hey genes in cardiovascular development. Trends Cardiovasc Med 13: 221-226, 2003.
9. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC, and Srivastava D. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447, 2003.
10. Gessler M, Knobeloch KP, Helisch A, Amann K, Schumacher N, Rohde E, Fischer A, and Leimeister C. Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice. Curr Biol 12: 1601-1604, 2002.
11. Givertz MM, Colucci WS, and Braunwald E. Clinical aspects of heart failure: high-output failure; pulmonary edema. In: Heart Disease: A Textbook of Cardiovascular Medicine (6th ed.), edited by Braunwald E, Zipes DP, and Libby P. Philadelphia, PA: Saunders, 2001, p. 534-561.
12. Hardt SE and Sadoshima J. Negative regulators of cardiac hypertrophy. Cardiovasc Res 63: 500-509, 2004.
13. Ishiko E, Matsumura I, Ezoe S, Gale K, Ishiko J, Satoh Y, Tanaka H, Shibayama H, Mizuki M, Era T, Enver T, and Kanakura Y. Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. J Biol Chem 280: 4929-4939, 2005.
14. Iso T, Kedes L, and Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194: 237-255, 2003.
15. Iso T, Sartorelli V, Chung G, Shichinohe T, Kedes L, and Hamamori Y. HERP, a new primary target of Notch regulated by ligand binding. Mol Cell Biol 21: 6071-6079, 2001.
16. Iso T, Sartorelli V, Poizat C, Iezzi S, Wu HY, Chung G, Kedes L, and Hamamori Y. HERP, a novel heterodimer partner of HES/E(spl) in Notch signaling. Mol Cell Biol 21: 6080-6089, 2001.
17. Kang PM and Izumo S. Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med 9: 177-182, 2003.
18. Kathiriya IS, King IN, Murakami M, Nakagawa M, Astle JM, Gardner KA, Gerard RD, Olson EN, Srivastava D, and Nakagawa O. Hairy-related transcription factors inhibit GATA-dependent cardiac gene expression through a signal-responsive mechanism. J Biol Chem 279: 54937-54943, 2004.
19. Kokubo H, Lun Y, and Johnson RL. Identification and expression of a novel family of bHLH cDNAs related to Drosophila hairy and enhancer of split. Biochem Biophys Res Commun 260: 459-465, 1999.
20. Kokubo H, Miyagawa-Tomita S, Tomimatsu H, Nakashima Y, Nakazawa M, Saga Y, and Johnson RL. Targeted disruption of hesr2 results in atrioventricular valve anomalies that lead to heart dysfunction. Circ Res 95: 540-547, 2004.
21. Kook H, Lepore JJ, Gitler AD, Lu MM, Wing-Man Yung W, Mackay J, Zhou R, Ferrari V, Gruber P, and Epstein JA. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest 112: 863-871, 2003.
22. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS, Soudais C, and Leiden JM. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 11: 1048-1060, 1997.
23. Lee Y, Shioi T, Kasahara H, Jobe SM, Wiese RJ, Markham BE, and Izumo S. The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression. Mol Cell Biol 18: 3120-3129, 1998.
24. Leimeister C, Externbrink A, Klamt B, and Gessler M. Hey genes: a novel subfamily of hairy- and Enhancer of split-related genes specifically expressed during mouse embryogenesis. Mech Dev 85: 173-177, 1999.
25. Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, and Molkentin JD. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 276: 30245-30253, 2001.
26. Liang Q, Wiese RJ, Bueno OF, Dai YS, Markham BE, and Molkentin JD. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol 21: 7460-7469, 2001.
27. Liu ZP and Olson EN. Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase. Proc Natl Acad Sci USA 99: 2043-2048, 2002.
28. Lu J, McKinsey TA, Nicol RL, and Olson EN. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA 97: 4070-4075, 2000.
29. Molkentin JD and Dorn IG II. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63: 391-426, 2001.
30. Molkentin JD, Lin Q, Duncan SA, and Olson EN. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 11: 1061-1072, 1997.
31. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, and Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998.
32. Nakagawa O, Nakagawa M, Richardson JA, Olson EN, and Srivastava D. HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Dev Biol 216: 72-84, 1999.
33. O'Brien TX, Lee KJ, and Chien KR. Positional specification of ventricular myosin light chain 2 expression in the primitive murine heart tube. Proc Natl Acad Sci USA 90: 5157-5161, 1993.
34. Olson EN and Schneider MD. Sizing up the heart: development redux in disease. Genes Dev 17: 1937-1956, 2003.
35. Sakata Y, Kamei CN, Nakagami H, Bronson R, Liao JK, and Chin MT. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc Natl Acad Sci USA 99: 16197-16202, 2002.
36. Sakata Y, Koibuchi N, Xiang F, Youngblood JM, Kamei CN, and Chin MT. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation. J Mol Cell Cardiol. In press.
37. Sakata Y, Xiang F, Chen Z, Kiriyama Y, Kamei CN, Simon DI, and Chin MT. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Arterioscler Thromb Vasc Biol 24: 2069-2074, 2004.
38. Sambrano GR, Fraser I, Han H, Ni Y, O'Connell T, Yan Z, and Stull JT. Navigating the signalling network in mouse cardiac myocytes. Nature 420: 712-714, 2002.
39. Shin CH, Liu ZP, Passier R, Zhang CL, Wang DZ, Harris TM, Yamagishi H, Richardson JA, Childs G, and Olson EN. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110: 725-735, 2002.
40. Sprenkle AB, Murray SF, and Glembotski CC. Involvement of multiple cis elements in basal- and α-adrenergic agonist-inducible atrial natriuretic factor transcription. Roles for serum response elements and an SP-1-like element. Circ Res 77: 1060-1069, 1995.
41. Springhorn JP and Claycomb WC. Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem J 258: 73-78, 1989.
42. Sun JX, Kamei CN, Layne MD, Jain MK, Liao JK, Lee ME, and Chin MT. Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2. J Biol Chem 276: 18591-18596, 2001.
43. Svensson EC, Huggins GS, Lin H, Clendenin C, Jiang F, Tufts R, Dardik FB, and Leiden JM. A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2. Nat Genet 25: 353-356, 2000.
44. Tevosian SG, Deconinck AE, Tanaka M, Schinke M, Litovsky SH, Izumo S, Fujiwara Y, and Orkin SH. FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 101: 729-739, 2000.
45. Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, and Olson EN. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110: 479-488, 2002.
46. Zhong TP, Rosenberg M, Mohideen MAPK, Weinstein B, and Fishman MC. Gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287: 1820-1824, 2000.